Advanced

AJNR - American Journal of Neuroradiology

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Takanashi, J.-i. Articles by Kohno, Y. Search for Related Content PubMed PubMed Citation Articles by Takanashi, J.-i. Articles by Kohno, Y.

American Journal of Neuroradiology 20:1822-1828 (11 1999)
© 1999 American Society of Neuroradiology

ARTICLE

MR-Revealed Myelination in the Cerebral Corticospinal Tract as a Marker for Pelizaeus-Merzbacher's Disease with Proteolipid Protein Gene Duplication

Jun-ichi Takanashi^,a, Katsuo Sugita^a, Yuzo Tanabe^a, Kasumi Nagasawa^a, Ken Inoue^a, Hitoshi Osaka^a and Yoichi Kohno^a

^a From the Department of Pediatrics, Faculty of Medicine (J.T., K.N., Y.K.), Department of Clinical Medicine, Faculty of Education (K.S.), Chiba University, Division of Neurology, Chiba Children's Hospital (Y.T.), Japan, the Department of Molecular and Human Genetics, Baylor College of Medicine (K.I.), Houston, and the Department of Pharmacology, University of California (H.O.), San Diego.

BACKGROUND AND PURPOSE: Pelizaeus-Merzbacher's disease (PMD) is caused by mutations in the proteolipid protein (PLP) gene. Recent studies have shown that an increased PLP dosage, resulting from total duplication of the PLP gene, invariably causes the classic form of PMD. The purpose of this study was to compare the MR findings of PMD attributable to PLP duplication with those of PMD arising from a missense mutation.

METHODS: Seven patients with PMD, three with a PLP missense mutation in either exon 2 or 5 (patients 1–3), and four with PLP duplication (patient 4 having larger PLP duplication than patients 5–7) were clinically classified as having either the classic or connatal form of PMD. Cerebral MR images were obtained to analyze the presence of myelination and T1 and T2 shortening in the deep gray matter. Multiple MR studies were performed in six of the seven patients to analyze longitudinal changes.

RESULTS: Four patients (patients 1–4) were classified as having connatal PMD, whereas the other three (patients 5–7) were classified as having classic PMD. Myelination in the cerebral corticospinal tract, optic radiation, and corpus callosum was observed in three cases of classic PMD with PLP duplication. In patient 4, myelination extended to the internal capsule, corona radiata, and centrum semiovale over a 3-year period. No myelination was observed in three PMD cases with a PLP point mutation. T2 shortening in the deep gray matter was recognized in all patients with PMD.

CONCLUSION: The presence of myelination in the cerebral corticospinal tract with diffuse white matter hypomyelination on MR images could be a marker for PMD with PLP duplication. It is suggested that progression of myelination may be present in connatal PMD with large PLP duplication.

This article has been cited by other articles:

				M. Bugiani, S. Al Shahwan, E. Lamantea, A. Bizzi, E. Bakhsh, I. Moroni, M. R. Balestrini, G. Uziel, and M. Zeviani GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy Neurology, July 25, 2006; 67(2): 273 - 279. [Abstract] [Full Text] [PDF]

				J. Takanashi, K. Inoue, M. Tomita, A. Kurihara, F. Morita, H. Ikehira, S. Tanada, E. Yoshitome, and Y. Kohno Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication Neurology, January 22, 2002; 58(2): 237 - 241. [Abstract] [Full Text] [PDF]